Neonatal sepsis in rural India: timing, microbiology, and antibiotic resistance in a population-based prospective study in the community setting

[1]  Z. Bhutta,et al.  Infection Surveillance Protocol for a Multicountry Population-based Study in South Asia to Determine the Incidence, Etiology and Risk Factors for Infections Among Young Infants of 0 to 59 Days Old , 2016, The Pediatric infectious disease journal.

[2]  P. Panigrahi,et al.  Challenges in Implementation of the ANISA Protocol at the Odisha Site in India , 2016, The Pediatric infectious disease journal.

[3]  R. Laxminarayan,et al.  Antibiotic Resistance in India: Drivers and Opportunities for Action , 2016, PLoS medicine.

[4]  F. Esamai,et al.  Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-label, equivalence trial , 2015, The Lancet.

[5]  Jamie Perin,et al.  Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis , 2015, The Lancet.

[6]  J. Carlin,et al.  Etiology of Bacteremia in Young Infants in Six Countries , 2014, The Pediatric infectious disease journal.

[7]  S. Cousens,et al.  Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis , 2014, The Lancet. Infectious Diseases.

[8]  I. Rudan,et al.  Aetiology of community-acquired neonatal sepsis in low and middle income countries , 2011, Journal of global health.

[9]  Judith A. Johnson,et al.  Extended-spectrum β-lactamase-producing Gram-negative bacteria causing neonatal sepsis in India in rural and urban settings , 2011 .

[10]  A. Zaidi,et al.  Pathogens Associated With Sepsis in Newborns and Young Infants in Developing Countries , 2009, The Pediatric infectious disease journal.

[11]  S. Gould,et al.  The withdrawal of antimicrobial treatment as a mechanism for defeating resistant microorganisms. , 2008, FEMS immunology and medical microbiology.

[12]  ASM Nawshad Uddin Ahmed,et al.  Clinical signs that predict severe illness in children under age 2 months: a multicentre study , 2008, The Lancet.

[13]  T. Taylor,et al.  Return of chloroquine antimalarial efficacy in Malawi. , 2006, The New England journal of medicine.

[14]  Z. Bhutta,et al.  Hospital-acquired neonatal infections in developing countries , 2005, The Lancet.

[15]  J. Carlin,et al.  Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. The WHO Young Infants Study Group. , 1999, The Pediatric infectious disease journal.

[16]  W. J. Novick.  Development of in vitro susceptibility testing criteria and quality control parameters , 1989 .

[17]  John B. Carlin,et al.  Clinical signs that predict severe illness in children underage 2 months: a multicentre study , 2008 .